{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:13:40Z","timestamp":1774977220181,"version":"3.50.1"},"reference-count":66,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Osteogenesis imperfecta\/Ehlers\u2013Danlos (OI\/EDS) overlap syndrome is a recently described disorder of connective tissue, characterized by mutation of COL1A1 (17q21.33) or COL1A2 (7q21.3) genes, that are involved in \u03b1-1 and \u03b1-2 chains of type 1 collagen synthesis. The clinical spectrum of this new clinical entity is broad: patients could present a mixed phenotype that includes features of both osteogenesis imperfecta (bone fragility, long bone fractures, blue sclerae, short stature) and Ehlers\u2013Danlos syndrome (joint hyperextensibility, soft and hyperextensible skin, abnormal wound healing, easy bruising, vascular fragility). We reported the case of a young Caucasian girl with severe short stature and a previous history of neuroblastoma, who displayed the compound phenotype of OI\/EDS. Next generation sequencing was applied to the proband and her parent genome. Our patient presented a de novo heterozygous COL1A1 variant (c.3235G&gt;A, p.Gly1079Ser), whose presence might be indicative of diagnosis of OI\/EDS overlap syndrome. We also hypothesize that the association with the previous history of neuroblastoma could be influenced by the presence of COL1A1 mutation, whose role has been already described in the behavior and progression of some cancers.<\/jats:p>","DOI":"10.3390\/genes13040581","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T15:31:21Z","timestamp":1648222281000},"page":"581","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Osteogenesis Imperfecta\/Ehlers\u2013Danlos Overlap Syndrome and Neuroblastoma\u2014Case Report and Review of Literature"],"prefix":"10.3390","volume":"13","author":[{"given":"Letteria Anna","family":"Morabito","sequence":"first","affiliation":[{"name":"Department of Human Pathology in Adulthood and Childhood, University of Messina, Gaetano Martino University Hospital, 98125 Messina, Italy"},{"name":"Pediatric Unit, Maternal Infant Department, San Giovanni di Dio Hospital, ASP Crotone, 88900 Crotone, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Elsa Maria","family":"Allegri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, IRCCS Giannina Gaslini Institute, 16147 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1428-3609","authenticated-orcid":false,"given":"Anna Paola","family":"Capra","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-1259","authenticated-orcid":false,"given":"Mario","family":"Capasso","sequence":"additional","affiliation":[{"name":"CEINGE Advanced Biotecnology, 80131 Napoli, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Capra","sequence":"additional","affiliation":[{"name":"Medical Genetics Unit, IRCCS Giannina Gaslini Institute, 16147 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garaventa","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, IRCCS Giannina Gaslini Institute, 16147 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-5238","authenticated-orcid":false,"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, IRCCS Giannina Gaslini Institute, 16147 Genova, Italy"},{"name":"Department of Neurosciences, Rehabilitation, Ophtalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Briuglia","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-2677","authenticated-orcid":false,"given":"Malgorzata Gabriela","family":"Wasniewska","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adulthood and Childhood, University of Messina, Gaetano Martino University Hospital, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"BSR20181409","DOI":"10.1042\/BSR20181409","article-title":"Compound phenotype of osteogenesis imperfecta and Ehlers Danlos syndrome caused by a combined mutations in COL1A1 and COL5A1","volume":"39","author":"Lin","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: Clinical diagnosis, nomenclature, and severity assessment","volume":"164","author":"Sillence","year":"2014","journal-title":"Am. J. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","article-title":"New genes in bone development: What\u2019s the new in osteogenesis imperfecta","volume":"98","author":"Marini","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum. Mutat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/ajmg.a.61366","article-title":"Nosology and classification of genetic skeletal disorders: 2019 revision","volume":"179","author":"Mortier","year":"2019","journal-title":"Am. J. Med. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100734","DOI":"10.1016\/j.bonr.2020.100734","article-title":"Histopathology of osteogenesis imperfecta bone. Supramolecular assessment of cells and matrices in the context of woven and lamellar bone formation using light, polarization and ultrastructural microscopy","volume":"14","author":"Shapiro","year":"2020","journal-title":"Bone Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.gim.0000223557.54670.aa","article-title":"Genetic evaluation of suspected osteogenesis imperfecta","volume":"8","author":"Byers","year":"2006","journal-title":"Genet. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"28417","DOI":"10.1038\/srep28417","article-title":"Next-generation sequencing of common osteogenesis imperfecta-related genes in clinical practice","volume":"6","author":"Arvai","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ajmg.a.38035","article-title":"Delineation of Ehlers\u2013Danlos syndrome phenotype due to the mutation (c.934C>T, p.Arg312Cys) in COL1A1: Report on a three-generation family without cardiovascular events, and literature review","volume":"173","author":"Ritelli","year":"2017","journal-title":"Am. J. Med. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1096-8628(19971003)72:1<94::AID-AJMG20>3.0.CO;2-O","article-title":"Ehlers\u2013Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen","volume":"72","author":"Byers","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajmg.a.38135","article-title":"Tissue-specific mosaicism for a lethal osteogenesis imperfecta COL1A1 mutation causes mild OI\/EDS overlap syndrome","volume":"173","author":"Symoens","year":"2017","journal-title":"Am. J. Med. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.c.31552","article-title":"The 2017 international classification of the Ehlers\u2013Danlos syndromes","volume":"175","author":"Malfait","year":"2017","journal-title":"Am. J. Med. Genet. Part. C Semin Med. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/cge.13683","article-title":"COL1-related overlap disorder: A novel connective tissue incoroporating the osteogenesis imperfecta\/Ehlers Danlos syndrome overlap","volume":"97","author":"Morlino","year":"2020","journal-title":"Clin. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01241398-199305000-00023","article-title":"Etiology and pathogenesis of heritable connective tissue diseases","volume":"13","author":"Cole","year":"1993","journal-title":"J. Pediatric Orthop."},{"key":"ref_15","first-page":"19","article-title":"Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type VII","volume":"106","author":"Raff","year":"2000","journal-title":"Hum. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1750-1172-8-78","article-title":"Helical mutations in type I collagen that afect the processing of the amino-propeptide result in an Osteogenesis Imperfecta\/Ehlers Danlos Syndrome overlap syndrome","volume":"8","author":"Malfait","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00247-006-0153-y","article-title":"Pediatric DXA: Technique and interpretation","volume":"37","author":"Binkovitz","year":"2007","journal-title":"Pediatric Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/ejhg.2015.81","article-title":"Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta","volume":"23","author":"Lindahl","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_20","first-page":"19","article-title":"Mutation analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients","volume":"11","author":"Zhytnik","year":"2017","journal-title":"Hum. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/humu.20456","article-title":"Y-position cysteine substitution in type I collagen (alpha1(I) R888C\/p.R1066C) is associated with osteogenesis imperfecta\/Ehlers Danlos syndrome phenotype","volume":"28","author":"Cabral","year":"2007","journal-title":"Hum. Mutat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jmg.38.2.132","article-title":"Homozigosity for a splice site mutation of the COL1A2 gene yields a non functional pro(\u03b1)2(I) chain and an EDS\/OI clinical phenotype","volume":"38","author":"Nicholls","year":"2001","journal-title":"J. Med. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.7695699","article-title":"Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution","volume":"266","author":"Bella","year":"1994","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11688","DOI":"10.1021\/bi00094a027","article-title":"Characterization of collagen-like peptides containing interruptions in the repeating Gly-X-Y sequence","volume":"32","author":"Long","year":"1993","journal-title":"Biochemistry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","article-title":"Collagen structure and stability","volume":"78","author":"Shoulders","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00219169","article-title":"Mild dominant osteogenesis imperfecta with intrafamilial variability: The cause is a serine for glycine \u03b1 1(I) 901 substitution in a type-I collagen gene","volume":"89","author":"Mottes","year":"1992","journal-title":"Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00439-011-1006-9","article-title":"Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8","volume":"130","author":"Kaneko","year":"2011","journal-title":"Hum. Genet."},{"key":"ref_28","first-page":"140","article-title":"Analysis of type IV osteogenesis imperfecta caused by two mutations occurred simultaneously in COL1A1 gene in a Chinese child","volume":"33","author":"Ju","year":"2016","journal-title":"Chin. J. Med. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/humu.20071","article-title":"Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients","volume":"27","author":"Hartikka","year":"2004","journal-title":"Hum. Mutat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4238\/2012.September.12.7","article-title":"Variable expressivity of osteogenesis imperfecta in a Brazilian family due to p.G1079S mutation in the COL1A1 gene","volume":"11","author":"Moraes","year":"2012","journal-title":"Genet. Mol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00223-008-9113-x","article-title":"Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations","volume":"82","author":"Roschger","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","article-title":"DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: Diagnostic yield and mutation spectrum","volume":"27","author":"Bardai","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Andersson, K., Dahll\u00f6f, G., Lindahl, K., Kindmark, A., Grigelioniene, G., \u00c5str\u00f6m, E., and Malmgren, B. (2017). Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta-A retrospective cohort study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176466"},{"key":"ref_34","first-page":"138","article-title":"A novel mutation in COL1A2 leads to osteogenesis imperfecta\/Ehlers Danlos overlap syndrome with brachydactyly","volume":"6","author":"Budsamongkol","year":"2019","journal-title":"Genet. Dis."},{"key":"ref_35","first-page":"R95","article-title":"Osteogenesis imperfecta: An update on clinical features and therapies","volume":"183","author":"Marom","year":"2020","journal-title":"Eur. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00774-011-0284-6","article-title":"The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta","volume":"30","author":"Zhang","year":"2012","journal-title":"J. Bone Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1098-1004(1998)12:2<138::AID-HUMU17>3.0.CO;2-D","article-title":"Identification of a new heterozygous point mutation in the COL1A2 gene leading to skipping of exon 9 in a patient with joint laxity, hyperextensibility of skin and blue sclerae. Mutation in brief no. 166","volume":"12","author":"Feshchenko","year":"1998","journal-title":"Hum. Mutat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/excr.2000.4847","article-title":"Mechanoregulation of chondrocyte proliferation, maturation and hypertrophy: Ion-channel dependent transduction of matrix deformation signals","volume":"256","author":"Wu","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2018.12.111","article-title":"Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of Osteogenesis imperfecta","volume":"509","author":"Scheiber","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","article-title":"Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I.; III, and IV","volume":"111","author":"Zeitlin","year":"2003","journal-title":"Pediatric"},{"key":"ref_41","first-page":"813","article-title":"Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-1 and IGFBP-3 levels","volume":"29","author":"Hobing","year":"2016","journal-title":"J. Pediatric Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000197874","article-title":"Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner Syndrome","volume":"71","author":"Boum","year":"2009","journal-title":"Horm. Res. Paediatr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kumps, C., Campos-Xavier, B., Hilhorst-Hofstee, Y., Marcelis, C., Kraenzlin, M., Fleischer, N., Unger, S., and Superti-Furga, A. (2020). The Connective Tissue Disorder Associated with Recessive Variants in the SLC39A13 Zinc Transporter Gene (Spondylo-Dysplastic Ehlers-Danlos Syndrome Type 3): Insights from Four Novel Patients and Follow-Up on Two Original Cases. Genes, 11.","DOI":"10.3390\/genes11040420"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.ajhg.2008.05.001","article-title":"Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome\u2014An autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13","volume":"82","author":"Giunta","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","unstructured":"Writing Group for Practice Guidelines for Diagnosis and Treatment of Genetic Diseases Medical Genetics Branch of Chinese Medical Association, Li, C., Xie, B., Shen, Y., and Luo, F. (2020). Clinical practice guidelines for Prader-Willi syndrome. Chin. J. Med. Genet., 37, 318\u2013323."},{"key":"ref_46","first-page":"685459","article-title":"Osteogenesis imperfecta, pseudoachalasia, and gastric cancer","volume":"2015","author":"Mizrak","year":"2015","journal-title":"Case Rep. Gastrointest. Med."},{"key":"ref_47","first-page":"44","article-title":"Osteogenesis imperfecta: Biochemical cancer resistance? Family pedigree and review of literature","volume":"66","author":"Rosenstock","year":"1970","journal-title":"Tex Med."},{"key":"ref_48","first-page":"314","article-title":"Osteosarcoma occurring in osteogenesis imperfecta. Report of two cases","volume":"49","author":"Klenerman","year":"1967","journal-title":"Bone Jt. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00428-004-0985-5","article-title":"Osteosarcoma occurring in osteogenesis imperfecta","volume":"444","author":"Takahashi","year":"2004","journal-title":"Virchows Arch."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0959-8049(95)00573-0","article-title":"Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta","volume":"32","author":"Beuzeboc","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10545-006-0438-1","article-title":"Carcinoma of left colon presenting as mechanical obstruction in a patient with osteogensesis imperfecta type III","volume":"30","author":"Augustin","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02767334","article-title":"Concurrent ovarian serous carcinoma and osteogenesis imperfecta","volume":"253","author":"Nishida","year":"1993","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_53","first-page":"1466","article-title":"A case of advanced colon cancer associated with osteogenesis imperfecta","volume":"34","author":"Fukushima","year":"2001","journal-title":"J. Gastrointest. Surg."},{"key":"ref_54","first-page":"665","article-title":"Osteogenesis imperfecta and breast carcinoma. A case study of radiobiological interest","volume":"170","author":"Bohler","year":"1994","journal-title":"Strahelnther. Onkol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s12282-011-0303-4","article-title":"An osteogenesis imperfecta case with breast cancer","volume":"21","author":"Taira","year":"2014","journal-title":"Breast Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"The International Neuroblastoma Risk Group (INRG) staging system: An INRG task force report","volume":"27","author":"Monclair","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10555-020-09843-4","article-title":"Genetic predisposition and chromosome instability in neuroblastoma","volume":"39","author":"Tonini","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/pbc.29038","article-title":"Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification","volume":"68","author":"Berthold","year":"2021","journal-title":"Pediatric Blood Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2008.17.5877","article-title":"Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification","volume":"27","author":"Gerrard","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"21840","DOI":"10.18632\/oncotarget.8187","article-title":"Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression","volume":"7","author":"Lasorsa","year":"2016","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s43018-020-00145-w","article-title":"Super enhancers define regulatory subtypes and cell identity in neuroblastoma","volume":"2","author":"Gartlgruber","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline Mutations in Predisposition Genes in Pediatric Cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3892\/or.2020.7905","article-title":"MicroRNA642a5p inhibits colon cancer cell migration and invasion by targeting collagen type I \u03b11","volume":"45","author":"Wang","year":"2021","journal-title":"Oncol. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.2147\/OTT.S249667","article-title":"miR-133b Suppresses Invasion and Migration of Gastric Cancer Cells via the COL1A1\/TGF-\u03b2 Axis","volume":"13","author":"Guo","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1515\/med-2021-0001","article-title":"CircRNA circ_0004370 promotes cell proliferation, migration, and invasion and inhibits cell apoptosis of esophageal cancer via miR-1301-3p\/COL1A1 axis","volume":"16","author":"Chen","year":"2021","journal-title":"Open Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"112153","DOI":"10.1016\/j.yexcr.2020.112153","article-title":"Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis","volume":"394","author":"Li","year":"2020","journal-title":"Exp. Cell Res."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/4\/581\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:43:00Z","timestamp":1760136180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/4\/581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["genes13040581"],"URL":"https:\/\/doi.org\/10.3390\/genes13040581","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]}}}